Cancer Research Articles

A study conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) evaluating the use of a new therapy to improve chemotherapy treatment outcomes was published in the October issue of the International Journal of Cancer Care and Delivery.

Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), will participate as a panelist for the Patient-Centered Oncology Care® (PCOC) conference presented by The American Journal of Managed Care® (AJMC) on November 9 – 10, 2022 in Nashville, TN.

Florida Healthcare Specialists (FHS), a division of Florida Cancer Specialists & Research Institute, LLC (FCS), held a ribbon-cutting ceremony on November 3, 2022 to celebrate the opening of a new clinical site in Vero Beach, FL, dedicated to urologic care.

You may have heard the terms Mindful Eating or Intuitive Eating floating around in the news or social media. What do these terms mean? Will these practices help you meet your healthy eating goals?

Physicians and leaders of Florida Cancer Specialists & Research Institute, LLC (FCS) joined key influencers and oncology care professionals at the 2022 National Community Oncology Dispensing Association (NCODA) International Fall Summit held in Orlando, Oct. 27 – 29. 

Florida Cancer Specialists & Research Institute, LLC (FCS) has submitted an application to participate in Medicare’s Enhancing Oncology Care Model (EOM), an alternative payment model that aims to address healthcare inequities, reduce costs and improve and report outcomes for cancer patients.

Physicians, clinicians and senior leaders of Florida Cancer Specialists & Research Institute, LLC (FCS) will continue their long history of active involvement with the Florida Society of Clinical Oncology (FLASCO) at the FLASCO Fall Session being held in Orlando, Oct. 28 & 29. 

Florida Cancer Specialists & Research Institute (FCS) pleased to announce that Josh Eaves has been appointed as Chief Development & Strategy Officer, reporting to Chief Executive Officer Nathan H. Walcker.